Search

everythinglearnresearchcommunity

for

Search:↓

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

New treatments focusing on immune pathways show promise for stubborn hair loss.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.